PSA PROGRESSION
Clinical trials for PSA PROGRESSION explained in plain language.
Never miss a new study
Get alerted when new PSA PROGRESSION trials appear
Sign up with your email to follow new studies for PSA PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Short radiation blitz tested to stop prostate Cancer's return
Disease control OngoingThis study is testing a short, high-precision form of radiation therapy for men whose prostate cancer shows signs it might come back after surgery. The goal is to see if this 5-treatment approach is as effective as traditional, longer radiation courses at keeping the cancer away,…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Common mushroom tested as potential prostate cancer fighter
Disease control OngoingThis study is testing whether a supplement made from white button mushrooms can help control prostate cancer. It is for men whose cancer has returned after initial treatment (shown by rising PSA levels) and for men with low-risk cancer who are being monitored without treatment. R…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New strategy aims to outsmart resistant prostate cancer
Disease control OngoingThis study is testing different combinations of approved drugs to find better ways to control advanced prostate cancer that has spread and stopped responding to standard hormone therapy. It involves 196 men and uses a personalized approach: after an initial 8-week treatment, pati…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New hope for tough prostate cancer: adding immunotherapy when standard drug fails
Disease control OngoingThis study is testing if adding the immunotherapy drug pembrolizumab can help control advanced prostate cancer that has started growing again despite treatment with the standard drug enzalutamide. It involves about 58 men whose cancer has spread and is no longer responding to hor…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC